SCHEMBL6079967

SCHEMBL6079967

O=C(O)N[C@@H]1CCN(CCc2c(Cl)cnc3ccc(Cl)cc23)C[C@@H]1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.38
CNR2 P34972 3/20 0.37
MEN1 O00255 1/20 0.36
MAPK10 P53779 1/20 0.36
KMT2A Q03164 1/20 0.36
KCNH2 Q12809 4/20 0.36
CNR1 P21554 2/20 0.36
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36
CCND3 P30281 1/20 0.36
CDK6 Q00534 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HTR1A P08908 2/20 0.35
HTR2A P28223 1/20 0.34
HTR7 P34969 1/20 0.34
HTR6 P50406 1/20 0.34
UBE2M P61081 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6079976 1.00 SLC2A1 (0.38) SLC2A1CNR2MEN1MAPK10KMT2A
SCHEMBL6080508 0.91 SLC2A1 (0.40) SLC2A1CNR2KCNH2CDK4CCND1
SCHEMBL6080502 0.91 SLC2A1 (0.40) SLC2A1CNR2KCNH2CDK4CCND1
SCHEMBL6079762 0.85 CNR2 (0.45) SLC2A1CNR2MEN1MAPK10KMT2A
SCHEMBL6080374 0.82 SSTR2 (0.37) SLC2A1MEN1MAPK10KMT2AKCNH2
SCHEMBL5747202 0.78 SLC2A1 (0.47) SLC2A1KCNH2
SCHEMBL5747000 0.78 SLC2A1 (0.47) SLC2A1KCNH2
SCHEMBL5746995 0.78 SLC2A1 (0.47) SLC2A1KCNH2
Hydrochloric Acid SCHEMBL5746982 0.78 KCNH2 (0.61) SLC2A1KCNH2
SCHEMBL6079796 0.77 SLC2A1 (0.53) SLC2A1KCNH2CDK4CCND1CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060041123-A1 Antibacterial agents GLAXO GROUP LIMITED (GB) 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060041123-A1 Antibacterial agents NQO2, NRDC, IFNG SLC2A1 4409/4885CNR2 4489/4885MEN1 3325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.